Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.
- 1 January 2001
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 55 (1) , 51-58
- https://doi.org/10.1023/a:1012946812930
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4ALeukemia, 2000
- Alterations of the INK4a/ARF locus in human intracranial germ cell tumors.2000
- Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaLeukemia, 1999
- Primary Central Nervous System Lymphomas in 72 Immunocompetent Patients: Pathologic Findings and Clinical CorrelationsAmerican Journal of Clinical Pathology, 1998
- Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.1997
- Transcriptional repression by the proto-oncogene BCL-6.1996
- Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The massachusetts general hospital experience 1958-1989Cancer, 1994
- Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell linesAnnals of Oncology, 1994
- Primary Central Nervous System LymphomaBrain Pathology, 1992
- Primary malignant lymphomas of the central nervous systemCancer, 1974